Back
Speaker illustration

Doctor Dion Candelaria

University of Sydney, Sydney (Australia)

Member of:

Mr. Candelaria is a Registered Nurse with extensive clinical experience in cardiothoracic and coronary care nursing. He was also a Research Associate at the Sydney Quality of Life Office at The University of Sydney where he developed a deeper understanding of the conceptual underpinnings and the practical application of patient-reported outcomes (PROs) and health-related quality of life (HRQL). He is currently completing his PhD, which focuses on understanding health-related quality of life outcomes from different models of cardiac rehabilitation (CR), particularly remote delivery during COVID-19 pandemic. His research will inform patient-centred quality improvement initiatives to improve patient outcomes and promote equitable access to CR. He has published several peer-reviewed articles on patient outcomes in CR and has won prizes and awards. He aims to submit his PhD thesis in mid-2022 and plans to pursue a research career.

Presentations Articles

Women achieve equivalent health-related quality of life benefits to men from attending cardiac rehabilitation: a matched case-control study

Event: ACNAP Congress 2023

Topic: Cardiovascular Rehabilitation

Session: Pearls of research on cardiac rehabilitation

Access
Thumbnail

Do ethnic minorities improve in exercise capacity following cardiac rehabilitation? a secondary analysis

Event: ACNAP Congress 2023

Topic: Cardiovascular Rehabilitation

Session: Pearls of research on cardiac rehabilitation

Access
Thumbnail

Predictors of poor exercise self-efficacy improvements after cardiac rehabilitation

Event: ESC Preventive Cardiology 2022

Topic: Cardiovascular Rehabilitation

Session: ePosters

Access
Thumbnail

Human connection: a valuable element for health-related quality of life outcomes in cardiac rehabilitation during COVID-19

Event: EuroHeartCare - ACNAP Congress 2021

Topic: Cardiovascular Rehabilitation

Session: ePosters

Access
Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb